Tumor-Informed Assessment Of Molecular Residual Disease And Its Incorporation Into Practice For Patients With Early And Advanced-Stage Colorectal Cancer (Crc-Mrd Consortia).

Pashtoon Murtaza Kasi,Farshid Dayyani,Van K. Morris,Scott Kopetz,Aparna Raj Parikh,Jason Scott Starr,Stacey Cohen, Axel Grothey,Christopher Hanyoung Lieu,Mark H. O'Hara,Kate Loranger,Laura Westbrook,Shruti Sharma,Shifra Krinshpun,Nicole Hook,Bernhard Zimmermann,Paul R. Billings,Alexey Aleshin

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 11|浏览44

暂无评分

摘要

4108Background: Circulating tumor DNA (ctDNA) testing can be used for the assessment of molecular residual disease (MRD) in patients with early-stage or advanced colorectal cancer (CRC). Prospectiv...

查看译文

关键词

colorectal cancer,molecular residual disease,tumor-informed,advanced-stage,crc-mrd

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要